Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
HAUP running hard!
Thanks. I thought BDY(old BPRX) was within your radar. One of your old stocks MVIS has been showing a lot of life lately. Wondering whether you might get interested in it once again..
Zeev, Are you looking at TBL at this price? Seems to have taken a lot of beating. Also what do you think of BDY at this point?
What do you think of HAUP at this point? If I remember right you had an OB around 2.7.
Do you plan to get back into TBL soon? If so at what price?
Do you still have GIVN? Also BDY has broken out, are you in it?
SKX on the move...
Did you see PDII today. Upward guidance almost by 80%. Have a long term 4 bagger. where do you think it's going?
Edit: Where do you see GIVN going short term and long?
Thanks,
snp
Zeev, Do you think CATS is a good breakout buy or is it too late?
Zeev, SEMI seems to be frolicking today on 4 times the avg. volume. Where do you see it going?
Zeev, Is ZRAN worth a swing trade here or do you see it going down further.
Zeev, OVTI started tanking after the following article appeared on the latest issue of fortune..
http://www.fortune.com/fortune/investing/articles/0,15114,457274,00.html
Any Idea what's up with HAUP. Huge move up today. What's the target?
Any Idea why AGM is dragging it's feet? Should it be accumulated here?
What do you think about orphans like SEMI ? Trading in such issues seem to be completely dead. I thought SEMI showed some activity last week, but we seem to be back to square one.
Zeev, GIVN seems be having problems selling their systems. They have even postponed their profitability to begining of 2004. What is your opinion regarding their quarter and their prospects?
Zeev, AGM seems to have stalled around here. Do you find it as attractive as before( I mean as a core.)? Or do you think it's prudent to wait for a better entry point? As always your views are much appreciated.
Zeev, One of your orphans "HOOK" moving big today. You still in it?
Zeev, How low do you think ZRAN could go at the height of the Nassacre?
Zeev, Would IART interest you once again? It's been enjoying the earnings rally today. Also what do you think about ZRAN?
Zeev, any idea what is happening with COO.
Thanks a lot for your insight. I really appreciate it.
Zeev, Do you think SWTX can go much lower than 1 ? Do you have a GTC below 1?
Zeev, ZRAN seems to be strong lately. Do you think it is a buy here ?
What do you think of IMCL breakout? Also NOVN making new highs.
Where do you think PII goes from here? When will you buy it as a core?
Zeev what do you think about OMG & AGM at these prices ?
Zeev, Is this a good time to get into PII? Do you still have the OB at 46 and change?
Zeev, PII has been very weak recently. Seems to be making new lows everyday (almost). You think it has a chance of going sub 46?
WDFC, How low do you think this will go before it stabilizes?
Zeev, Any idea what's ailing WDFC?
BPRX As per Raymond James.. Thanks to a post on the yahoo board.
Bradley Pharmaceuticals, Inc.
(BPRX:NASDAQ) Strong Buy 1
Bradley: 4th-Qtr Earnings Suggest Upside to 2003 Estimate
Bradley Pharmaceuticals on Feb. 26 said fourth quarter earnings
surged 55% to $0.18 per share, matching our target and beating the top end of its guidance by 2 cents.
Including a gain from the sale of investments, earnings were $0.19 per share.
Results bolster confidence that our 2003 earnings estimate of $0.82 per share will prove low.
Bradley plans to provide earnings guidance at the Raymond James
Institutional Investors Conference next week. The company is
scheduled to present at 10:35 a.m. March 4.
Our confidence stems from the fact that fourth-quarter revenue, up 42% to $11.1 million, exceeded our estimate by $700,000.
Earnings matched our target even though Bradley spent money to
hire sales people, a move likely to boost 2003 sales.
Sales of Bradley's Carmol line of damaged skin treatments grew
89% to $7.4 million and are on track to exceed our 2003 estimate of $28 million.
Our 2003 estimate of $0.82 per share and our 2004 estimate of
$0.96 are unchanged.
We reiterate our Strong Buy rating and our price target of $20.50,based on Bradley's 2003 earnings growth rate of 25% times its estimated 2003 earnings per share of $0.82.
Zeev, BPRX has come out with great results but still languishing due to a dearth of buyers ( or "they" trying to shake weak hands). Looks like a good opportunity for making a few bucks. What do you think?
Zeev, Do you think ZRAN could go to 13.5 - 14 before going back down?
SKX : In all fairness they did come up with loss narrower than 25 - 35 cents namely 23 cents. In their own words when they provided their new guidance...
"increased revenue would result in a loss that is narrower than the 25 cents to 35 cents a share it previously projected for the fourth quarter."
IMCL - Talk about reg FD.
"Somebody thinks they know something and that we're going to get something out of the Merck data soon," said Jim McCamant, an analyst at Moors Cabot. "ImClone should have that data in hand by now."
Last week Patrick Mooney, an analyst at Thomas Weisel Partners, raised his investment recommendation on ImClone to "buy" from "market perform." He said he believes data from two pivotal clinical trials, including Merck's, will be positive and form the basis for regulatory filings both in Europe and the U.S.
Zeev, Is that a short squeeze on IMCL? Do you think someone knows something we dont. Up 21% !
Zeev, Do you think PII can touch 56 on this run ?
Zeev, DO you think NOVN is baseing at around here?
Zeev, GIVN where do you see it during the Nassacre?